Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties

From computational simulations of a serotonin 2A receptor (5-HT2AR) model complexed with pharmacologically and structurally diverse ligands we identify different conformational states and dynamics adopted by the receptor bound to the full agonist 5-HT, the partial agonist LSD, and the inverse agonist Ketanserin. The results from the unbiased all-atom molecular dynamics (MD) simulations show that the three ligands affect differently the known GPCR activation elements including the toggle switch at W6.48, the changes in the ionic lock between E6.30 and R3.50 of the DRY motif in TM3, and the dynamics of the NPxxY motif in TM7. The computational results uncover a sequence of steps connecting these experimentally-identified elements of GPCR activation. The differences among the properties of the receptor molecule interacting with the ligands correlate with their distinct pharmacological properties. Combining these results with quantitative analysis of membrane deformation obtained with our new method (Mondal et al, Biophysical Journal 2011), we show that distinct conformational rearrangements produced by the three ligands also elicit different responses in the surrounding membrane. The differential reorganization of the receptor environment is reflected in (i)-the involvement of cholesterol in the activation of the 5-HT2AR, and (ii)-different extents and patterns of membrane deformations. These findings are discussed in the context of their likely functional consequences and a predicted mechanism of ligand-specific GPCR oligomerization.

[1]  Graeme Milligan,et al.  Identification of a serotonin/glutamate receptor complex implicated in psychosis , 2008, Nature.

[2]  S. Sealfon,et al.  Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex , 2003, The Journal of Neuroscience.

[3]  Arthur Christopoulos,et al.  A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity , 2008, Journal of Biological Chemistry.

[4]  osé Morenoa,et al.  etabotropic glutamate mGlu 2 receptor is necessary for the pharmacological nd behavioral effects induced by hallucinogenic 5-HT 2 A receptor agonists , 2011 .

[5]  H. Weinstein,et al.  Active State-like Conformational Elements in the β2-AR and a Photoactivated Intermediate of Rhodopsin Identified by Dynamic Properties of GPCRs† , 2008, Biochemistry.

[6]  C. Nichols Serotonin 5-HT2A Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases , 2009, Cardiovascular psychiatry and neurology.

[7]  B. Roth,et al.  Arresting serotonin , 2008, Proceedings of the National Academy of Sciences.

[8]  W. Weis,et al.  Structural insights into G-protein-coupled receptor activation. , 2008, Current opinion in structural biology.

[9]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[10]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[11]  S. W. Lin,et al.  Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. , 1996, Biochemistry.

[12]  George Khelashvili,et al.  GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base , 2010, Bioinform..

[13]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[14]  E. sanders-Bush,et al.  Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors , 2002, Neuroscience.

[15]  Davide Provasi,et al.  Ligand-Induced Modulation of the Free-Energy Landscape of G Protein-Coupled Receptors Explored by Adaptive Biasing Techniques , 2011, PLoS Comput. Biol..

[16]  Harel Weinstein,et al.  Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor , 2002, The Journal of Biological Chemistry.

[17]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[18]  L. Luttrell,et al.  Refining efficacy: exploiting functional selectivity for drug discovery. , 2011, Advances in pharmacology.

[19]  J. Ramachandran,et al.  Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.

[20]  Terry Kenakin,et al.  Ligand-selective receptor conformations revisited: the promise and the problem. , 2003, Trends in pharmacological sciences.

[21]  Harel Weinstein,et al.  The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site. , 2008, Molecular cell.

[22]  R. Seifert,et al.  Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities , 2009, Molecular Pharmacology.

[23]  H Weinstein,et al.  Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor , 1996, The Journal of Biological Chemistry.

[24]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[25]  M. Jochum,et al.  Helix 8 Plays a Crucial Role in Bradykinin B2 Receptor Trafficking and Signaling , 2011, The Journal of Biological Chemistry.

[26]  J. González-Maeso Anxious interactions , 2010, Nature Neuroscience.

[27]  S. Feller,et al.  Molecular simulations and solid-state NMR investigate dynamical structure in rhodopsin activation. , 2012, Biochimica et biophysica acta.

[28]  Krzysztof Palczewski,et al.  Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.

[29]  D. C. Mitchell,et al.  Regulation of membrane proteins by dietary lipids: effects of cholesterol and docosahexaenoic acid acyl chain-containing phospholipids on rhodopsin stability and function. , 2008, Biophysical journal.

[30]  P. Sexton,et al.  Determination of Adenosine A1 Receptor Agonist and Antagonist Pharmacology Using Saccharomyces cerevisiae: Implications for Ligand Screening and Functional Selectivity , 2009, Journal of Pharmacology and Experimental Therapeutics.

[31]  H. Lester,et al.  The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation study , 1992, FEBS letters.

[32]  J. Ballesteros,et al.  Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage* , 2002 .

[33]  H Weinstein,et al.  Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. , 1996, Molecular pharmacology.

[34]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[35]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[36]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[37]  Harel Weinstein,et al.  A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains. , 2005, Journal of the American Chemical Society.

[38]  Wayne A Hendrickson,et al.  Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor , 2008, EMBO reports.

[39]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[40]  Tod D Romo,et al.  Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics. , 2010, Biophysical journal.

[41]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[42]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[43]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[44]  B. Kobilka G protein coupled receptor structure and activation. , 2007, Biochimica et biophysica acta.

[45]  P Ghanouni,et al.  Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  George Khelashvili,et al.  Quantitative modeling of membrane deformations by multihelical membrane proteins: application to G-protein coupled receptors. , 2011, Biophysical journal.

[47]  B. Roux,et al.  Absolute binding free energy calculations of sparsomycin analogs to the bacterial ribosome. , 2010, The journal of physical chemistry. B.

[48]  Javier González-Maeso,et al.  Agonist-trafficking and hallucinogens. , 2009, Current medicinal chemistry.

[49]  Alexander D. MacKerell,et al.  Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..

[50]  B. Roth,et al.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.

[51]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[52]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[53]  A. Poso,et al.  A Proton Relay Process as the Mechanism of Activation of the Histamine H3-Receptor Determined by 1H NMR and ab Initio Quantum Mechanical Calculations , 2000 .

[54]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[55]  E. Hermans,et al.  Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. , 2010, Biochemical pharmacology.

[56]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[57]  Michael J. Crawley,et al.  The R book , 2022 .

[58]  H Weinstein,et al.  Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model. , 1986, Molecular pharmacology.

[59]  C. Altenbach,et al.  High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation , 2008, Proceedings of the National Academy of Sciences.

[60]  Michael R. Braden,et al.  Assessment of the Roles of Serines 5.43(239) and 5.46(242) for Binding and Potency of Agonist Ligands at the Human Serotonin 5-HT2A Receptor , 2007, Molecular Pharmacology.

[61]  Arthur Christopoulos,et al.  Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.

[62]  Vadim Cherezov,et al.  A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.

[63]  P. Sexton,et al.  Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. , 2010, ACS chemical biology.

[64]  R. Levenson,et al.  Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target , 2011, PloS one.

[65]  N. Heveker,et al.  Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands , 2009, Journal of Pharmacology and Experimental Therapeutics.

[66]  Leonardo Pardo,et al.  Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer , 2009, The EMBO journal.

[67]  K. Hideg,et al.  Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. , 1993, Science.

[68]  B. Roth,et al.  A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. , 2000, The Journal of pharmacology and experimental therapeutics.

[69]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[70]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[71]  Sandhya Kortagere,et al.  Ab initio computational modeling of long loops in G-protein coupled receptors , 2006, J. Comput. Aided Mol. Des..

[72]  Thomas Huber,et al.  G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. , 2007, Journal of the American Chemical Society.

[73]  Clay W Scott,et al.  Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity , 2009, Journal of biomolecular screening.

[74]  Xavier Deupi,et al.  Coupling ligand structure to specific conformational switches in the β2-adrenoceptor , 2006, Nature chemical biology.

[75]  J. Javitch,et al.  CODA-RET reveals functional selectivity as a result of GPCR heteromerization , 2011, Nature chemical biology.

[76]  George Khelashvili,et al.  Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations , 2009, Proteins.

[77]  Harel Weinstein,et al.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors , 2005, The AAPS Journal.

[78]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[79]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[80]  Xavier Deupi,et al.  Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.

[81]  Thomas L. James,et al.  Docking to RNA via Root-Mean-Square-Deviation-Driven Energy Minimization with Flexible Ligands and Flexible Targets , 2008, J. Chem. Inf. Model..

[82]  Terry Kenakin Functional selectivity in GPCR modulator screening. , 2008, Combinatorial chemistry & high throughput screening.

[83]  O. Andersen,et al.  Hydrophobic Coupling of Lipid Bilayer Energetics to Channel Function , 2003, The Journal of general physiology.

[84]  Mark S.P. Sansom,et al.  Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices , 2000 .

[85]  H. Weinstein,et al.  The binding sites for cocaine and dopamine in the dopamine transporter overlap , 2008, Nature Neuroscience.

[86]  MC-PHS: a Monte Carlo implementation of the primary hydration shell for protein folding and design. , 2003, Biophysical journal.

[87]  K. Palczewski,et al.  Role of membrane integrity on G protein-coupled receptors: Rhodopsin stability and function. , 2011, Progress in lipid research.

[88]  H. Weinstein,et al.  Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. , 2003, Molecular Pharmacology.

[89]  T. Kenakin,et al.  Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. , 2011, Methods in molecular biology.

[90]  Gebhard F. X. Schertler,et al.  Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.

[91]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[92]  Tsutomu Kouyama,et al.  Crystal structure of squid rhodopsin , 2008, Nature.

[93]  Kunhong Xiao,et al.  Multiple ligand-specific conformations of the β2-adrenergic receptor. , 2011, Nature chemical biology.

[94]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[95]  D. C. Mitchell,et al.  Optimization of Receptor-G Protein Coupling by Bilayer Lipid Composition I , 2001, The Journal of Biological Chemistry.

[96]  Ron O Dror,et al.  Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.

[97]  T. Gallaher,et al.  Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. , 1993, Molecular pharmacology.

[98]  Marta Filizola,et al.  Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer , 2006, J. Comput. Aided Mol. Des..

[99]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[100]  S. Sealfon,et al.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists , 2011, Neuroscience Letters.

[101]  G. Milligan,et al.  Selectivity and functional consequences of interactions of family A G protein‐coupled receptors with neurochondrin and periplakin , 2009, Journal of neurochemistry.

[102]  R. Mailman GPCR functional selectivity has therapeutic impact. , 2007, Trends in pharmacological sciences.

[103]  Tod D Romo,et al.  A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor* , 2010, The Journal of Biological Chemistry.

[104]  Mihaly Mezei,et al.  Simulaid: A simulation facilitator and analysis program , 2010, J. Comput. Chem..

[105]  Robert P. Millar,et al.  Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[106]  K. Palczewski,et al.  Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. , 2008, Annual review of pharmacology and toxicology.

[107]  H. Weinstein,et al.  Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices. , 2000, Trends in pharmacological sciences.

[108]  M. Maeda,et al.  FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. , 2006, Biochemical and biophysical research communications.

[109]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[110]  G. Voth,et al.  A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor. , 2009, Structure.

[111]  H Weinstein,et al.  Prokink: a protocol for numerical evaluation of helix distortions by proline. , 2000, Protein engineering.

[112]  Harel Weinstein,et al.  Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation , 2009, Neuropharmacology.

[113]  Marta Filizola,et al.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[114]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[115]  Sergio A Hassan,et al.  Ab initio computational modeling of loops in G‐protein‐coupled receptors: Lessons from the crystal structure of rhodopsin , 2006, Proteins.

[116]  G Vriend,et al.  The essential dynamics of thermolysin: Confirmation of the hinge‐bending motion and comparison of simulations in vacuum and water , 1995, Proteins.

[117]  H. Weinstein,et al.  Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. , 2001, Biochemistry.

[118]  H. Weinstein,et al.  The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter , 2011, PloS one.

[119]  Thomas Huber,et al.  Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes. , 2006, Biophysical journal.

[120]  H. Weinstein,et al.  Probing the structural determinants for the function of intracellular loop 2 in structurally cognate G-protein-coupled receptors. , 2010, Biochemistry.

[121]  K. Fahmy,et al.  Transducin-dependent protonation of glutamic acid 134 in rhodopsin. , 2000, Biochemistry.